Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 3 | 2024 | 153 | 0.330 |
Why?
|
| Heart Transplantation | 3 | 2024 | 366 | 0.270 |
Why?
|
| Tetralogy of Fallot | 2 | 2021 | 83 | 0.260 |
Why?
|
| Heart Bypass, Right | 1 | 2024 | 15 | 0.230 |
Why?
|
| Arteriovenous Fistula | 1 | 2024 | 30 | 0.220 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 41 | 0.220 |
Why?
|
| Blood Proteins | 1 | 2024 | 83 | 0.220 |
Why?
|
| Anesthesia, General | 1 | 2024 | 99 | 0.220 |
Why?
|
| Fontan Procedure | 1 | 2024 | 70 | 0.210 |
Why?
|
| Arteriovenous Malformations | 1 | 2024 | 76 | 0.210 |
Why?
|
| Proteome | 1 | 2024 | 161 | 0.200 |
Why?
|
| Cardiac Catheterization | 1 | 2024 | 223 | 0.200 |
Why?
|
| Proteomics | 1 | 2024 | 313 | 0.190 |
Why?
|
| Pulmonary Atresia | 1 | 2021 | 23 | 0.180 |
Why?
|
| Angioplasty, Balloon | 1 | 2021 | 67 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2011 | 294 | 0.140 |
Why?
|
| Graft Rejection | 1 | 2015 | 173 | 0.110 |
Why?
|
| Infant | 5 | 2024 | 3648 | 0.100 |
Why?
|
| Child, Preschool | 5 | 2024 | 3953 | 0.100 |
Why?
|
| Child | 6 | 2024 | 6931 | 0.100 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2011 | 4 | 0.100 |
Why?
|
| Reoperation | 2 | 2011 | 461 | 0.090 |
Why?
|
| Amiodarone | 1 | 2011 | 22 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 80 | 0.090 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2010 | 10 | 0.090 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2011 | 38 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2024 | 6274 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2010 | 84 | 0.080 |
Why?
|
| Heart Failure | 1 | 2015 | 531 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 165 | 0.080 |
Why?
|
| Quantum Dots | 1 | 2008 | 12 | 0.080 |
Why?
|
| Immunoglobulin Fragments | 1 | 2008 | 14 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 44 | 0.070 |
Why?
|
| Nanotechnology | 1 | 2008 | 36 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2009 | 156 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2011 | 1030 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 6453 | 0.060 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 603 | 0.050 |
Why?
|
| Male | 6 | 2024 | 25866 | 0.050 |
Why?
|
| Humans | 9 | 2024 | 50419 | 0.050 |
Why?
|
| Female | 6 | 2024 | 27053 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2021 | 5265 | 0.040 |
Why?
|
| Survival Rate | 2 | 2011 | 906 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 2231 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 2933 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2011 | 2752 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 189 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 48 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 103 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 482 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 434 | 0.020 |
Why?
|
| Fluoroimmunoassay | 1 | 2008 | 3 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 98 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 1451 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 1268 | 0.020 |
Why?
|
| Arkansas | 1 | 2010 | 1974 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 3712 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4075 | 0.010 |
Why?
|